Term
|
Definition
SNS
Gq
Increases vascular smooth muscle contraction, increases pupillary dilator muscle contraction (mydriasis), increases intestinal and bladder sphincter muscle contraction
Decreases renin release |
|
|
Term
|
Definition
SNS
Gi
Decrease SNS outflow, Decrease Insulin release, Decrease Lipolysis, Increase Plt aggregation
Drugs that Block A2: Clonidine, Methyldopa, Yohimbine, Mertazapine |
|
|
Term
|
Definition
SNS
Gs
Increase HR, Increase Contractility, Increase Renin, Increase Lipolysis |
|
|
Term
|
Definition
SNS
Gs
Vasodilation, Bronchodilation, Increase HR, Increase Contractility, Increase Lipolysis, Increase Insulin resistance, Increase Aqueous Humor Production
Decrease Uterine tone (tocolysis); Ciliary muscle relaxation
*NE has NO B2 EFFECTS |
|
|
Term
|
Definition
PNS
Gq
CNS, Enteric nervous system; Increased Gastric Motility? |
|
|
Term
|
Definition
PNS
Gi
Decreased HR and Contractility of Atria (SA nodal tissue) |
|
|
Term
|
Definition
PNS
Gq
Increased exocrine gland secretions (i.e. lacrimal, salivary, gastric acis), Increased gut peristalsis, Increased bladder contraction, bronchconstriction, Increased pupillary sphincter muscle contraction (miosis), ciliary muscle contraction (accomodation) |
|
|
Term
|
Definition
Dopamine
Gs
Relaxes renal vascular smooth muscle |
|
|
Term
|
Definition
Dopamine
Gi
Modulates transmitter release, especially in the brain |
|
|
Term
|
Definition
Histamine
Gq
Increased nasal and bronchial mucus production, Increased Vascular permeability, contraction of bronchioles, pruritis, and pain |
|
|
Term
|
Definition
Histamine
Gs
Increased Gastric Acid Secretion |
|
|
Term
|
Definition
Vasopressin
Gq
Increased Vascular smooth muscle contraction |
|
|
Term
|
Definition
Vasopressin
Gs
Increased H2O permeability and reabsorption in the collecting tubules of the kidney (V2 is found in the 2 Kidneys) |
|
|
Term
|
Definition
H1 a1, V1, M1, M3
HAVe 1 M&M
IP3 DAG pathway |
|
|
Term
|
Definition
MAD 2's
M2, a2, D2
Inhibits Adenylyl cyclase |
|
|
Term
|
Definition
B1, B2, D1, H2, V2
Stimulate Adenylyl cyclase |
|
|
Term
Drugs that bind Presynaptic A2 receptors |
|
Definition
These drugs decrease release of NE
Clonidine
Methyldopa
Yohimbine
Mirtazapine |
|
|
Term
|
Definition
Cholinomimetic
Use: Postoperative ileus, neurogenic ileus and urinary retention
Action: Activates bowel and bladder smooth muscle; resistant to AChE. "Bethany, call (bethanechol) me, maybe, if you tant to activate your bowels and bladder."
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
Cholinomimetic agent
Clinical: Glaucoma, pupillary constriction, and relief of intraocular pressure
Action: Carbon copy of acetylcholine
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
Cholinomimetic agent
Clinical: Potent stimulator of sweat, tears and saliva; Open-angle and closed angle glaucoma
Action: Contracts ciliary muscle of eye (open-angle glaucoma), pupillary sphincter (closed-angle glaucoma); resistant to AChE. "You cry, drool, and sweat on your 'pillow'".
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
Cholinomimetic
Clinical: Challenge test for diagnosis of asthma
Action: Stimulates muscarine receptors in airway when inhaled.
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
AChEsterase
Clinical: Postpop and neurogenic ileus and urinary retention, myasthenia gravis, reversal of NMJ block (post op)
Action: Increase endogenous ACh.
Neo CNS = No CNS penetration
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
AChEsterase
Clinical: Myasthenia gravis (long acting); does not penetrate CNS
Action: Increase endogenous ACh; Increase strength. Pyridostigmine gets rid of myasthenia gravis
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
AChEsterase
Clinical: Anticholinergic toxicity (crosses blood-brain barrier -> CNS)
Action: Increase endogenous ACh. Physostigmine "phyxes" atropine overdose
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
|
Definition
AChE
Clinical: Alzheimer's disease
Action: Increases endogenous ACh
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers
Other Drugs: Rivastigmine, Galantamine |
|
|
Term
|
Definition
AChE
Clinical: Alzheimer's disease
Action: Increases endogenous ACh
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers
Other Drugs: Donepezil, Galantamine |
|
|
Term
|
Definition
AChE
Clinical: Alzheimer's disease
Action: Increases endogenous ACh
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers
Other Drugs: Rivastigmine, Donepezil |
|
|
Term
|
Definition
AChEsterase
Clinical: Historically, diagnosis of myasthenia gravis (extremely short acting). Myasthenis now diagnosed by anti-AChR Ab (anti-acetylcholine receptor antibody) test.
Action: Increase endogenou ACh
Side Effects: Watch for exacerbation of COPD, asthma and peptic ulcers |
|
|
Term
Symptoms of Cholinesterase Inhibitor Poisoning |
|
Definition
DUMBBELSS (aka PNS stimulation)
Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Excitation of skeletal muscle and CNS, Lacrimation, Sweating and Salivation
Often due to organophosphates, such as parathion, that irreversibly inhibits AChE; found in insecticides; poisoning usually seen in farmers
Antidote - atropine (competitive inhibitor) + pralidoxime (regenerates AChE if given early) |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Eye
Application: Produce mydriasis and cycloplegia
Other Drugs: homatropine, tropicamide |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Eye
Application: Produce mydriasis and cycloplegia
Other Drugs: Atropine, Tropicamide |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Eye
Application: Produce mydriasis and cycloplegia
Other Drugs: Atropine, homatropine |
|
|
Term
|
Definition
Muscarinic Antagonist
Organ: CNS
Applications: Parkinson's disease - "Park my Benz" |
|
|
Term
|
Definition
Muscarinic Antagonist
Organ: CNS
Applications: Motion Sickness |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Respiratory system
Application: COPD, asthma ("I pray I can breath soon!")
Other Drugs: Tiotropium |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Respiratory system
Application: COPD, asthma ("I pray I can breath soon!")
Other Drugs: Ipratropium |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Genitourinary
Applications: Reduce urgency in mild cystitis and reduce bladder spasms |
|
|
Term
|
Definition
Muscarinic antagonist
Organ: Gastrointestinal, respiratory
Applications:
-Parenteral: preoperative use to reduce airway secretions
-Oral: drooling, peptic ulcer |
|
|
Term
|
Definition
Muscarinic Antagonist
Use: Bradycardia, ophthalmic applications
Organs: Eye=↑pupil ↑pupil dilation; Airway =↓secretions Stomach = ↓acid secretion; Gut = ↓motility; Bladder = ↓urgency in cystitis
Action: blocks DUMBBeLSS
Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Lacrimation, Sweating and Salivation; skeletal muscle and CNS excitation mediated by nicotinic receptors
Toxicity: Hot as a hare, Dry as a bone, Red as a beet, Blind as a bat, Mad as a hatter; can be cause by Jimson weed (Datura) -> gardener's pupil (mydriasis due to plant alkaloids)
Can cause acute angle-closure glaucoma in elderly (due to mydriasis), urinary retention in men with prostatic hyperplasia and hyperthermia in infants
|
|
|
Term
|
Definition
Sympathomimetic
Effec: B (at low dose) >a (at high dose)
Applications: Anaphylaxis, open angle glaucoma, asthma, hypotension; alpha effects predominate at high doses |
|
|
Term
|
Definition
Sympathomimetic
a1>a2>B1
Applications: Hypotension (but ↓ renal perfusion) |
|
|
Term
|
Definition
Sympathomimetic
B1=B2
Applications: Electrophysiologic evaluation of tacharrhythmias. Can worsen ischemia |
|
|
Term
|
Definition
Sympathomimetic
D1=D2>B>a
Applications: Unstable bradycardia, heart failure, shock; inotropic and chronotropic a effects predominat at high doses |
|
|
Term
|
Definition
Sympathomimetic
B1>B2, a
Applications: Heart failure (inotropic>chronotropic), cardiac stress testing |
|
|
Term
|
Definition
Sympathomimetic
a1>a2
Hypotension (vasoconstrictor), ocular procedure (mydriatic), rhinitis (decongestant) |
|
|
Term
|
Definition
Sympathomimetic
B2>B1
Applications: Acute asthma
Similar Drugs: Salmetrol, Terbutaline |
|
|
Term
|
Definition
Sympathomimetic
B2>B1
Applications: Long term asthma or COPD
Similar drugs: Albuterol, terbutaline |
|
|
Term
|
Definition
Sympathomimetic
B2>B1
Applications: Reduce premature uterine contractions
Similar drugs: Albuterol, Salmetrol |
|
|
Term
|
Definition
Indirect sympathomimetic
Effect: Indirect general agonist, reuptake inhibitor, also releases stored catecholamines
Applications: Narcolepsy, obesity, ADD |
|
|
Term
|
Definition
Indirect Sympathomimetic
Effect: Indirec general agonist, releases stored catecholamines
Applications: Nasal decongestion, urinary incontinence, hypotension |
|
|
Term
|
Definition
Indirect sympathomimetic
Effect: Indirect general agonist, reuptake inhbitor
Applications: Causes vasoconstriction and local anesthesia; never give B-blockers if cocaine intoxication is suspected (can lead to unopposed a1 activation and extreme hypertension) |
|
|
Term
|
Definition
Sympatholytic (a2-agonist)
Applications: Hypertensive urgency (limited situations); does not decrease renal blood flow; ADHD, severe pain and a variety of off-label indications (e.g. ethanol and opioid withdrawal)
Toxicity: CNS depression, bradycardia, hypotension, respiratory depression, and small pupil size |
|
|
Term
|
Definition
Sympatholytic (a2-agonist)
Applications: Hypertension in pregnancy, safe in pregnancy
Toxicity: Direct Coombs +, hemolytic anemia, SLE-like syndrome |
|
|
Term
|
Definition
Nonselective alpha blocker - irreversible
Application: Pheochromocytoma (use phenoxybenzamine before removing tumor, since high levels of released catecholamines will not be able to overcome blockage)
Toxicity: Orthostatic hypotension, reflex tachycardia |
|
|
Term
|
Definition
Nonselective alpha blocker - reversible
Applications: Give to pts on MAOI who eat tyramine-containing foods |
|
|
Term
|
Definition
a1 blocker (-zosin)
Application: HTN, urinary retention in BPH
Tox: 1st-dose orthostatic hypotension, dizziness, headache |
|
|
Term
|
Definition
a1 blocker (-zosin)
Application: HTN, urinary retention in BPH
Tox: 1st-dose orthostatic hypotension, dizziness, headache |
|
|
Term
|
Definition
a1 blocker (-zosin)
Application: HTN, urinary retention in BPH
Tox: 1st-dose orthostatic hypotension, dizziness, headache |
|
|
Term
|
Definition
a2 blocker
Application: Depression
Tox: Sedation, ↑ serum cholestrol, ↑ appetite |
|
|
Term
|
Definition
A BEAM = B1 antagonists (B1>B2) - Acebutolol (partial agonist), Betaxolol, Esmolol (Short acting), Atenolol, Metoprolol
Use: HTN, angina pectoris, MI, SVT (propranolol, esmolol), CHF, Glaucoma
Toxicity: impotence, exacerbation of asthma, CV effects, CNS effects (sedation, sleep alteration); use with caution in diabetics
|
|
|
Term
Nonselective Beta Blockers |
|
Definition
Please Try Not βeing Picky = Propranolol, Timolol, Nadolol and Pindolol
Use: HTN, angina pectoris, MI, SVT (propranolol, esmolol), CHF, Glaucoma
Toxicity: impotence, exacerbation of asthma, CV effects, CNS effects (sedation, sleep alteration); use with caution in diabetics |
|
|
Term
Nonselective (vasodilatory) alpha and beta blockers |
|
Definition
|
|
Term
|
Definition
PAPA = Partial B-Agonist - Pindolol, Acebutolol |
|
|
Term
|
Definition
a-agonist
↑ outflow of aqeuous humor
Side effects: Mydriasis, stinging; do not use in closed-angle glaucoma |
|
|
Term
|
Definition
↓aqueous humor synthesis
Side effects: No pupillary or vision changes |
|
|
Term
|
Definition
Timolol, betaxolol, carteolol
↓aqueous humor secretion
Side effects: No pupillary or vision changes |
|
|
Term
Cholinomimetics for Glaucoma |
|
Definition
Pilocarpine, carbachol, physostigmine, echothiophate
Mechanism: Ciliary muscle contraction, opening of trabecular meshwork; ↑ outflow of aqueous humor
Side effects: Miosis, cyclospasm |
|
|
Term
Diuretics as Glaucoma drugs |
|
Definition
Acetazolamide, dorzolamide, brinzolamide
Mechanism: decrease aqueous humor secretion due to decreased HCO3- (via inhibition of carbonic anhydrase)
Side effects: No pupillary or vision changes |
|
|
Term
|
Definition
Prostaglandin for Glaucoma
Mechanism: Increased outflow of aqueous humor
Side effects: Darkens color of iris (browning) |
|
|
Term
|
Definition
Not used clinically
Competes with choline for uptake into presynaptic cleft |
|
|
Term
|
Definition
Competes with ACh for packaging into vessicles |
|
|
Term
|
Definition
Inhibits synaptobrevin (snare protein) inhibitng fusion of vessicles to the presynaptic membrane
result is flaccid paralysis; prevents sweating too |
|
|
Term
|
Definition
Inhibits conversion of Tyrosine to DOPA
Decrease sympathetic outflow |
|
|
Term
|
Definition
Inhibits packaging of catecholamines into presynaptic vessicles
Decrease sympathetic outflow |
|
|
Term
|
Definition
Replaces the Catecholamines in the presynaptic vessicles
Decrease sympathetic outflow |
|
|